Newark, NJ, May 30, 2022 (GLOBE NEWSWIRE) — As per the report published by Fior Markets, The global cold plasma market is expected to grow from USD 1.5 billion in 2019 to USD 4.8 billion by 2027, at a CAGR of 15.6% during the forecast period 2020-2027. The Asia-Pacific region stands as a promising market for cold plasma and is expected to grow at the highest CAGR during the forecast period. This growth in the APAC region is motivated by an increased demand for decontaminated frozen food, technological advancements in the semiconductor industry and rising manufacturing in sectors like electronics, polymer and textile. The markets in Thailand, China, India and Japan, are proliferating, commanding significant shares in the regional market.
Get Free Sample Copy: https://www.fiormarkets.com/report-detail/418336/request-sample
Key players in the global cold plasma market are Europlasma, SOFTAL Corona & Plasma, Molecular Plasma Group, Apyx Medical Corporation, Henniker Plasma, U.S. Medical Innovations, Tantec A/S, Nordson Corporation, UNIQAIR Technologies, Terraplasma GmbH, Neoplas GmbH, CINOGY GmbH, Relyon Plasma GmbH, PlasmaLeap Technologies, Adtec Plasma Technology Co. Ltd., Enercon Industries, Ferrarini & Benelli, Coating Plasma Innovation, P2i, Europlasma, Surfx Technologies, LLC, and Advanced Plasma Solutions among others. Key companies are mainly focusing on developing new products, forming partnerships, and joint ventures to gain significant market share in the…
